Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
8,679,431
-
Share change
-
-2,352,587
-
Total reported value
-
$11,887,247
-
Put/Call ratio
-
199%
-
Price per share
-
$1.37
-
Number of holders
-
47
-
Value change
-
-$2,639,774
-
Number of buys
-
19
-
Number of sells
-
17
Institutional Holders of PROTEOSTASIS THERAPEUTICS IN - COM (PTI) as of Q2 2020
As of 30 Jun 2020,
PROTEOSTASIS THERAPEUTICS IN - COM (PTI) was held by
47 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,679,431 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., WINTON GROUP Ltd, Bain Capital Public Equity Management II, LLC, MACQUARIE GROUP LTD, HarbourVest Partners LLC, ACADIAN ASSET MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, BRIDGEWAY CAPITAL MANAGEMENT INC, and JPMORGAN CHASE & CO.
This page lists
47
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.